IsoRay, Inc. (ISR:NYSEMKT) rocketted at $0.49, representing a gain of 29.4%. On Wed 02 Dec 20, ISR:NYSEMKT touched a New 2-Week High of $0.38. The stock got featured on our News Catalysts scanner on Tue 24 Nov 20 at 10:33 AM in the 'MISCELLANEOUS' category. From Wed 18 Nov 20, the stock recorded 33.33% Up Days and 10.00% Green Days
The stock spiked on Thu 17 Sep 20 at $0.79 with a volume of 1M+, and its share price has been moving sideways in recent weeks.
About IsoRay, Inc. (ISR:NYSEMKT)
IsoRay Inc designs and develops personalized brachytherapy products. The company treats prostate cancer, brain, liver, breast cancer, colorectal cancer, gynecological cancer, lung cancer, ocular melanoma and pancreatic cancer.
Top 10 Gainers:
- Ever-Glory International Group, Inc. (EVK:NASDAQ), 150%
- Lizhi Inc. (LIZI:NASDAQ), 102.97%
- Waddell & Reed Financial, Inc. (WDR:NYSE), 50.44%
- Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ), 45.95%
- Nesco Holdings, Inc. (NSCO:NYSE), 37.93%
- Enlivex Therapeutics Ltd. (ENLV:NASDAQ), 37.85%
- IsoRay, Inc. (ISR:NYSEMKT), 29.4%
- Iterum Therapeutics plc (ITRM:NASDAQ), 29.38%
- Aehr Test Systems (AEHR:NASDAQ), 27.16%
- Aemetis, Inc. (AMTX:NASDAQ), 27.09%